Find a Research Study

Find a Research Study

Find a Research Study

Find a Research Study

Find a Research Study

Dysautonomia in Down Syndrome

The role of sympathetic nervous system (SNS) activation in the context of daily stressors which elevate both heart rate, blood pressure, and thereby catecholamine activation for individuals with Down syndrome (DS) remains unclear. Understanding the mechanisms underlying SNS dysfunction in DS is crucial, as it likely contributes to many clinical and developmental challenges, including the underlying reduced work capacity and therefore autonomic dysfunction in this population. Addressing this gap may enable targeted therapies to enhance survival and quality of life for individuals with DS.


Why this Research Matters

There are three peripheral SNS systems which are preferential to different catecholamine (i.e., EPI, NE, DOPA) release(s). These three systems include: 1) sympatho-adrenomedullary system; 2) sympatho-neural system; and 3) DOPA-dopamine autocrine/paracrine system. As such, we will use six sympathetic stressors to observe the catecholamine responses across these three peripheral systems in individuals with DS compared to age- and sex-matched individuals without DS. The six optional SNS stressors are 1) Cold Stress, 2) Fear via Virtual Reality, 3) Pain via Capsaicin Cream, 4) 12-Hour Fast, 5) Caffeine, and 6) Maximal Dynamic Exercise. Each of these stressors are optional.


Who can Participate

Adult

Individuals with and without DS Population: Individuals with and without DS Inclusion Criteria: - 18-50 yrs old and apparently healthy individuals - Ability to understand the study and give assent to participate - Has a study partner who can attend all visits for the individuals with DS, and answer questionnaires, provide consent when necessary - Corrected or non-existent congenital heart disease - Euthyroid or on stable thyroid medication dose for at least 6 months - Free from cardiovascular, pulmonary, inflammatory, or metabolic disease in the past 6 months that would prevent participation in study procedures - BMI <45kg/m2 - Ability to tolerate repeated blood draws / catheter placement Exclusion Criteria: - Hypertension (resting systolic blood pressure [SBP] >140 and/or diastolic blood pressure [DBP] >90 mmHg) this includes those on medications to treat hypertension - Hypotension (resting BP of <90/60 mmHg) - Cancer in the last six months - Any heart-rate-altering medications or any other medication that may modify metabolic responses - Self-reported diabetes or use of glucose-lowering medication - Tobacco products, including vaping, or marijuana use - Currently pregnant - Post-menopausal women Specific Exclusion Criteria for Certain Stressors: - Orthopedic limitations that would prohibit exercise or movement for exercise - Fracture of limb to be immersed for cold pressor test (CPT) - Open cut or sore on hand to be immersed for CPT - Raynauds syndrome for CPT - Chronic caffeine drinkers for caffeine stressor (consumption of caffeine in the last 7 days) Participants with and without DS will be grouped in a 1:1 fashion based on age and sex where possible, to minimize confounding effects and better isolate phenotype-specific differences associated with Trisomy 21.


Study ID

Protocol Number: 25-0503


Meet the Team

Image of Principal Investigator

Sara Sherman

Principal Investigator